OS was also assessed in the different prespecified PD-L1 expression subgroups (TC1/2/3 or IC1/2/3 [equivalent to expression levels of 1%, 5%, and 50% in tumor cells or immune cells infiltrating the tumor) [93]. The gene discussed is CD274; the disease is neoplasm.